RxDoctor Payments Data

James Moren

Family Medicine · Bellingham, WANPI 1255388427

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $83,648 of the $105,939 with a category attached, or 79.0%. 14 manufacturers reported payments, led by AbbVie at 33.2% of the total. Reporting peaked in 2021 at $34,549 and has fallen 99.7% since, to $114 in 2023. Among family medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$105,939in general payments, 2019–2025

Across 198 payments — averaging $535.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$35K
  • Teva Pharmaceuticals USA, Inc.$29K
  • Amgen$25K
  • Biohaven Pharmaceutical Holding Company Ltd.$6K
  • Biohaven Pharmaceuticals, Inc.$6K
  • Lundbeck LLC$4K
  • plus $367 from 8 others

What the payments were for

  • Consulting fees$9,7109%
  • Speaking & faculty fees$83,64879%
  • Travel & lodging$8,3868%
  • Food & beverage$4,1434%
  • Education$530%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$105,939 in reported general payments places this provider in the 95th percentile of 2,275 family medicine providers in Washington.

See all family medicine providers in Washington

Other family medicine in Bellingham

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →